Common Contracts
6 similar Underwriting Agreement contracts by Aflac Inc, International Game Technology, Onyx Pharmaceuticals Inc, others
Aflac Incorporated ¥13,000,000,000 1.048% Senior Notes due 2029 ¥27,900,000,000 1.412% Senior Notes due 2031 ¥7,700,000,000 1.682% Senior Notes due 2034 Underwriting AgreementUnderwriting Agreement • March 21st, 2024 • Aflac Inc • Accident & health insurance
Aflac Incorporated, a Georgia corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”), for whom Mizuho Securities USA LLC, Morgan Stanley & Co. International plc and SMBC Nikko Securities America, Inc. are acting as Representatives (the “Representatives”), an aggregate of ¥13,000,000,000 principal amount of the 1.048% Senior Notes due 2029 (the “2029 Notes”), ¥27,900,000,000 principal amount of the 1.412% Senior Notes due 2031 (the “2031 Notes”) and ¥7,700,000,000 principal amount of the 1.682% Senior Notes due 2034 (the “2034 Notes” and, together with the 2029 Notes and 2031 Notes, the “Securities”). The 2029 Notes will be issued under the Senior Debt Indenture, dated as of May 21, 2009 (the “Senior Debt Indenture”), as supplemented by the Thirty-Eighth Supplemental Indenture, to be dated as of March 21, 2024 (the “Thirty-Eighth Supplemental Indenture”), each between
Underwriting AgreementUnderwriting Agreement • June 8th, 2010 • International Game Technology • Miscellaneous manufacturing industries • New York
VALIDUS HOLDINGS, LTD. (a Bermuda holding company) Underwriting AgreementUnderwriting Agreement • January 26th, 2010 • Validus Holdings LTD • Fire, marine & casualty insurance • New York
Validus Holdings, Ltd., an exempted company incorporated in Bermuda as a holding company (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the underwriters named in Schedule I hereto (collectively, the “Underwriters,” which term shall also include any underwriter substituted as hereinafter provided in Section 10 hereof), for whom Goldman, Sachs & Co. is acting as representative (the “Representative”), an aggregate of $250,000,000 principal amount of 8.875% Notes due 2040 of the Company (the “Securities”).
Schweitzer-Mauduit International, Inc. Common Stock, par value $0.10 per share Underwriting AgreementUnderwriting Agreement • November 13th, 2009 • Schweitzer Mauduit International Inc • Paper mills • New York
Schweitzer-Mauduit International, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of 1,800,000 shares (the “Firm Securities”) and, at the election of the Underwriters, up to 270,000 additional shares (the “Optional Securities”) of Common Stock, par value $0.10 per share (“Stock”), of the Company (the Firm Securities and the Optional Securities that the Underwriters elect to purchase pursuant to Section 2 hereof being collectively called the “Securities”).
Onyx Pharmaceuticals, Inc. 4,000,000 Shares of Common Stock Underwriting AgreementUnderwriting Agreement • August 7th, 2009 • Onyx Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York
The undersigned understands that you, as representative (the “Representative”), propose to enter into (i) an Underwriting Agreement (the “Common Stock Underwriting Agreement”) on behalf of the several underwriters named in Schedule I to such agreement (the “Common Stock Underwriters”), with Onyx Pharmaceuticals, Inc., a Delaware corporation (the “Company”), providing for the offer and sale of the common stock of the Company, $0.001 par value per share (the “Stock”) and (ii) an Underwriting Agreement (the “Convertible Notes Underwriting Agreement”) on behalf of the several underwriters named in Schedule I to such agreement (the “Convertible Notes Underwriters”), with the Company, providing for the offer and sale of the Company’s Convertible Senior Notes due 2016 (the “Notes” and, together with the Stock, the “Securities”). The Notes will be convertible into shares of Stock.
Underwriting AgreementUnderwriting Agreement • December 10th, 2007 • Transocean Inc • Drilling oil & gas wells
As Representatives (the “Representatives”) of the several Underwriters named in Schedule I hereto, c/o Goldman, Sachs & Co. 85 Broad Street, New York, New York 10004.
